Patents by Inventor Stephan Abel

Stephan Abel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • N-phenyl-2-pyrimidine-amine derivatives
    Publication number: 20060142580
    Abstract: The present invention relates to novel amides and a process for preparing these amides.
    Type: Application
    Filed: February 6, 2003
    Publication date: June 29, 2006
    Inventors: Olivier Loiseleur, Daniel Kaufmann, Stephan Abel, Hans Burger, Mark Meisenbach, Beat Schmitz, Gottfried Sedelmeier
  • Production of 2-amino-2-(4-alkylphenyl)ethyl]propane-1,3-diols
    Publication number: 20060079715
    Abstract: Disclosed is a process for the production of 2-amino-2-[2-(4-C2-20-alkyl-phenyl)ethyl]propane-1,3-diols.
    Type: Application
    Filed: November 29, 2005
    Publication date: April 13, 2006
    Inventors: Stephan Abel, Tetsuro Fujita, Ryoji Hirose, Guido Jordine, Tadashi Mishina
  • Production of 2-amino-2-[2- (4-alkylphenyl) ethyl] propane-1, 3-diols
    Patent number: 7026522
    Abstract: Disclosed is a process for the production of 2-amino-2-[2-(4-C2-20-alkyl-phenyl)ethyl]propane-1,3-diols.
    Type: Grant
    Filed: June 18, 2003
    Date of Patent: April 11, 2006
    Assignee: Novartis AG
    Inventors: Stephan Abel, Tetsuro Fujita, Ryoji Hirose, Guido Jordine, Tadashi Mishina
  • Beta-homolysine conjugates and their use as transport enhancer
    Publication number: 20050118101
    Abstract: The present invention relates to a conjugate that comprises a) at least one compound to be delivered into or across a biological carrier, b) a delivery-enhancing transporter comprising at least 4 ?-homolysine residues, especially between 4 and 25 ?-homolysine residues, c) optionally a linker between the components a) and b), and d) optionally a labelling unit; to the salts of such conjugates; to a pharmaceutical composition comprising said conjugate; to a method for delivery of a compound into or across a biological barrier, the method comprising contacting the barrier with said conjugate; and to a process for the preparation of certain conjugates.
    Type: Application
    Filed: January 27, 2003
    Publication date: June 2, 2005
    Inventors: Olivier Loiseleur, Daniel Kaufmann, Stephan Abel, Hans-Michael Burger, Mark Meisenbach, Beat Schmitz, Gottfried Sedelmeier
  • Production of 2-amino-2-[2- (4-alkylphenyl) ethyl] propane-1, 3-diols
    Publication number: 20030229251
    Abstract: Disclosed is a process for the production of 2-amino-2-[2-(4-C2-20-alkyl-phenyl)ethyl]propane-1,3-diols.
    Type: Application
    Filed: June 18, 2003
    Publication date: December 11, 2003
    Inventors: Stephan Abel, Tetsuro Fujita, Ryoji Hirose, Guido Jordine, Tadashi Mishina
  • Production of 2-amin-2-[2-(2-(40-C2-20-alkyl-phenyl)ethyl]propane-1,3-diols
    Patent number: 6605744
    Abstract: Disclosed is a process for the production of 2-amino-2-[2-(4-C2-20-alkyl-phenyl)ethyl]propane-1,3-diols.
    Type: Grant
    Filed: May 8, 2001
    Date of Patent: August 12, 2003
    Assignees: Novartis AG, Taito Co. Ltd., Mitsubishi Pharma Corp.
    Inventors: Stephan Abel, Tetsuro Fujita, Ryoji Hirose, Guido Jordine, Tadashi Mishina
  • Production of 2-amino-2-[2-(4-C2-20-alkyl-phenyl)ethyl]propane-1,3-diols
    Publication number: 20020072635
    Abstract: Disclosed is a process for the production of 2-amino-2-[2-(4-C2-20-alkyl-phenyl)ethyl]propane-1,3-diols.
    Type: Application
    Filed: May 8, 2001
    Publication date: June 13, 2002
    Inventors: Stephan Abel, Tetsuro Fujita, Ryoji Hirose, Guido Jordine, Tadashi Mishina